Approved Hospital Formulary
Add Formweb to your mobile device
Search results for:
pegfilgrastim
pegfilgrastim
Brand names: Neulasta
| Form | Strength |
|---|---|
| SOLUTION, SUBCUTANEOUS | 6 mg/0.6 mL |
Last updated: Jan. 9, 2024
- RCRA: Disposal
- RCRA: Management of Pharmaceutical Waste Policy
- Restricted Restricted Medication
This medication is Inpatient Non-formulary and Restricted to Outpatient Use. Inpatient use requires approval by a physician department leader (i.e. Medical Director or Chair, or hospital CMO) collaborating with a pharmacy leader.
See HERE for more information and workflow.
See HERE for additional pharmacy workflow details.